CN107519395A - 一种预防和治疗动脉硬化的保健饮品及其制备方法 - Google Patents
一种预防和治疗动脉硬化的保健饮品及其制备方法 Download PDFInfo
- Publication number
- CN107519395A CN107519395A CN201710733034.5A CN201710733034A CN107519395A CN 107519395 A CN107519395 A CN 107519395A CN 201710733034 A CN201710733034 A CN 201710733034A CN 107519395 A CN107519395 A CN 107519395A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw material
- component
- artery sclerosis
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001367 artery Anatomy 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 34
- 208000034189 Sclerosis Diseases 0.000 title claims abstract description 32
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 38
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 26
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 26
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 15
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 14
- 241000219784 Sophora Species 0.000 claims abstract description 12
- 230000002265 prevention Effects 0.000 claims abstract description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 11
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 11
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 11
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 10
- 244000298479 Cichorium intybus Species 0.000 claims abstract description 10
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 10
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 9
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 9
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 14
- 244000269722 Thea sinensis Species 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 235000013616 tea Nutrition 0.000 claims description 7
- 235000009569 green tea Nutrition 0.000 claims description 6
- 230000004224 protection Effects 0.000 claims description 6
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 4
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 14
- 208000002173 dizziness Diseases 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 230000004438 eyesight Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000001627 cerebral artery Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical group 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 235000013073 Acorus gramineus Nutrition 0.000 description 1
- 241000219068 Actinidia Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000219051 Fagopyrum Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种预防和治疗动脉硬化的保健饮品及其制备方法,涉及保健食品领域,由A组分和B组分组成,所述A组分,由以下原料组成,山楂,葛根、绿饮品、苦荞麦、黄精;所述B组分,由以下原料中的至少一种组成,黄芪、槐米、决明子、菊花、菊苣、银杏叶、桑叶、余甘子、低聚木糖,以上原料为干料,此发明提供的保健饮品,对预防和治疗动脉硬化具有良好的效果,且口感良好,制备工艺简单,生产成本低。
Description
技术领域
本发明涉及保健食品领域,特别涉及一种预防和治疗动脉硬化的保健饮品及其制备方法。
背景技术
动脉硬化是动脉的一种非炎症性病变,可使动脉管壁增厚、变硬,失去弹性和管腔狭小。动脉硬化是随着年龄增长而出现的血管疾病,随着人们生活节奏的加快,工作压力的增加,膳食结构的变化,抽烟喝酒、偏食、饮食无节及休眠不足导致的脏器生理功能衰退等自我老化现象。特别在精神紧张、情绪激动或劳累后出现的头晕、头痛、眼花、耳鸣、失眠、乏力、注意力不集中等导致早期的动脉硬化,此病在青少年时期发生,至中老年时期加重、发病。现在我们国家正处在老龄化的阶段,动脉硬化导致的心脑血管病在逐年的增加。为此,以预防与食疗为主导,改善心脑供血、平衡血糖、血脂、改善动脉硬化。增强免疫功能,改善生活质量,提高生存能力,逐渐成为医学界、中医药领域研究的重点。
此病具有对人体健康危害大、发病率高、病程长等特点,给病人带来了极大的痛苦,西医尚无何特效药物,只是针对症状予降血脂、扩血管、改善脑部血液循环、改善脑代谢等治疗,疗效不确定,且易复发。脑动脉硬化属于祖国医学眩晕范畴,由于现代人长期精神紧张、熬夜加之工作压力大等,促使肝肾亏损,起居不慎或禀赋不足,致肝肾更加虚惫,风自内生,风木横克脾土,脾虚失于建运,则水停为湿,湿聚生痰,日久痰阻瘀生,蒙蔽清窍而发病,故而治疗本病,宜发扬中医整体观念、治病求本的特色,采用培补肝肾、调理脾胃、活血化瘀醒脑之法。
中国公开号为CN 102972594 A的发明专利公开了一种有效预防动脉硬化的降压饮品及其制备方法,属于医学保健饮品技术领域。其特征在于含有
重量百分含量的以下组分:西洋参18-27%、绞胶蓝13-25%、银杏叶11-21%、杜仲15-23%、罗布麻叶13-35%。此发明,虽然能预防动脉硬化、降血脂,
但是对于已经患有高血脂的患者来说,效果不明显,且原料成本高,且口感差,难以坚持长期服用。
又如中国公开号为CN 105362611 A的发明专利公开了一种防治动脉硬化和高血压的保健饮品及其制备方法,它包括下述原料按照下述质量份数制成:猕猴桃根35-45 份;蜂蜜80-100 份;云南白药60-80 份;石菖蒲25-35 份;茯苓25-35 份;韭菜150-250 份;夏枯草35-45 份;决明子35-45 份;黄苓35-45 份;水1200-1800 份;本发明还涉及一种防治动脉硬化和高血压的保健饮品,它包括取料、分料、煎熬、榨汁和混料步骤;此发明虽然可以同时对动脉硬化和高血压具有很好的防治效果,且口感良好,但是对于已经患有动脉硬化和高血压的患者来说,效果不明显,且生产工艺复杂,生产成本高。
发明内容
本发明所要解决的技术问题是提供一种预防和治疗动脉硬化的保健饮品及其制备方法,对预防和治疗动脉硬化具有良好的效果,且口感良好,制备工艺简单,生产成本低,以解决现有技术中导致的上述多项缺陷。
为实现上述目的,本发明提供以下的技术方案:一种预防和治疗动脉硬化的保健饮品,由A组分和B组分组成,所述A组分,由以下原料组成,山楂,葛根、绿饮品、苦荞麦、黄精;
所述B组分,由以下原料中的至少一种组成,黄芪、槐米、决明子、菊花、菊苣、银杏叶、桑叶、余甘子、低聚木糖,以上原料为干料。
优选的,所述A组分按重量份计,由以下重量份数的原料组成,山楂
50-130份,葛根30-80份、绿茶25-90份、苦荞麦50-160份、黄精40-100份 ;
所述B组分按重量份计,由以下重量份数的原料中的至少一种组成,黄芪30-80份、槐米20-60份、决明子10-30份、菊花10-20份、菊苣30-50份、银杏叶20-40份、桑叶25-45份、余甘子1-100份、低聚木糖1-10份。
优选的,所述A组分按重量份计,由以下重量份数的原料组成,山楂90份,葛根55份、绿饮品57.5份、苦荞麦105份、黄精70份 ;
所述B组分按重量份计,由以下重量份数的原料中的至少一种组成,黄芪55份、槐米40份、决明子20份、菊花15份、菊苣40份、银杏叶30份、桑叶35份、余甘子50.5份、低聚木糖5.5份。
一种预防和治疗动脉硬化的保健饮品的制备方法,包括以下工艺步骤:
(1)按照原料配比称重、去杂,清洗,然后微波烘干;
(2)将黄精按照古法三蒸三晒,苦荞麦在100-140℃的条件下进行40-60分钟烘培处理;
(3)将原料混合研磨成50目的粗粉;
(4)微波杀菌后饮品滤纸包装成8克/包,即为保健茶成品。
用法与用量:每日1-2包,每次取一包放在保温杯里,用沸水400-600ml冲泡10-20分钟后频饮,根据自己每天用水量,可以反复冲泡3-4次。
也可以制备成固体饮料,具体工艺步骤如下:
(1)按照原料配比称重、去杂,清洗,然后微波烘干;
(2)将黄精按照古法三蒸三晒,苦荞麦在100-140℃的条件下进行40-60分钟烘培处理;
(3)将烘培好的苦荞麦用超微粉碎机粉碎成超微粉,要求400目以上,再将其它原料混合,放入提取罐加水按照中药提取方法进行提取,将提取液浓缩至浸膏后同苦荞麦超微粉混合烘干打粉制成粉剂;
(4)将制成的粉剂用食品级包装袋包装成5克/袋,即为固体饮料成品。
用法与用量:每日1-2袋,温水冲服。
药理分析如下:
葛根,味甘、辛,性平,归脾、胃、肺、膀胱经。解肌退热;发表透诊;生津止渴;升阳止泻。主外感发热;头项强痛;麻疹初起;疹出不畅;温病口渴;消渴病;泄泻;痢疾;高血压;冠心病、心绞痛、耳聋。葛根含有约12%的黄酮类化合物,包括大豆(黄豆)甙、大豆甙元、葛根素等10余种;并含有胡萝卜甙、氨基酸、香豆素类等;还有蛋白质、氨基酸、糖、和人体必需的铁、钙、铜、硒等矿物质,是老少皆宜的名贵滋补品,有“千年人参”之美誉。《本草正义》谓葛根“最能开发脾胃清阳之气”。
苦荞麦,味苦,平。入心、脾、胃经。有理气止痛、健脾利湿的功效,苦荞麦有治疗胃痛、消化不良、腰腿疼痛、跌打损伤的作用,苦荞仁营养成分非常丰富。《本草纲目》中记载:苦荞麦性味苦、平寒,有益气力、续精神、利耳目、降气、宽肠健胃的作用。现代科研分析,苦荞仁营养成分极高,非常丰富,含有生物类黄酮、多种维生素、18种氨基酸、粗蛋白、叶绿素及其硒、锌、镁、铬、钙等矿物质及微量元素,其独特的营养成分是黄酮类物质,其主要成分为芦丁。芦丁又名芸香甙、维生素P,含量占总黄酮的70%-90%,具有降低毛细血管脆性、改善微循环的作用,对糖尿病、高血压有着很好的食效。
山楂,味酸、甘、微温。归脾、胃、肝经,山楂气血并走,化瘀而不伤新血,行滞气而不伤正气,应用于肉食积滞证,泻痢腹痛、疝气痛、瘀滞腹痛胸痛、恶露不尽、痛经、吐血、便血等。现代单用本品制剂治疗心血管疾病、细菌性痢疾等,均有较好疗效。山楂主要含有黄酮类、低聚黄烷类、有机酸类、微量元素,另外还有含有三萜类、甾体类和有机胺类等成分。近几年来,山楂在降血脂、降血压、抗脑血及其作用机制方面取得了重大进展。
黄精,味甘、性平,归脾、肺、肾经,具有健脾、补肾、润肺、生津等功能。《名医别录》将其列为上品,《本草经疏》:黄精君,纯得土之冲气,而禀乎季春之令,故味甘气和性无毒。其色正黄,味厚气薄,土位乎中,脾治中焦,故补中。脾土为后天生气之源,故益气。中气强,脾胃实,则风湿之邪不能干,故除风湿。五脏之气皆禀胃气以生,胃气者即后天之气也,斯气盛则五脏皆实,实则安,故安五脏。虽非治疗之所急,而为养性之上药。故仙经累赞其能服饵驻颜,久而弥胜矣。现代药理研究表明,黄精具有抗衰老、降血脂、防动脉粥样硬化、降血糖、调节免疫力等功效。
桑叶,其性寒,味甘、苦,有疏散风热、清肺润燥、清肝明目的功效,可治疗风热感冒,肺热燥咳,头晕头痛,目赤昏花的病症。现代中、西医把桑叶和桑叶生物制剂作为改善糖尿病及其他各种疑难杂症的药物而使用,认为其药效极为广泛。有清肺润燥、止咳、去热、化痰、治盗汗;补肝、清肝明目、治疗头晕眼花、失眠、消除眼部疲劳;消肿、清血‘治疗痢疾、腹痛、减肥、除脚气、利大、小肠;抗应激、凉血、降血压、降血脂、预防心肌梗塞、脑溢血、祛头痛、长发;降血糖、抗糖病等。
黄芪,味甘,性微温,归肝、脾、肺、肾经。有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。可用于体弱卫虚、肌表不固,自汗盗汗,或易感外邪;气虚水肿,疮痈难溃,或久溃不敛;及气虚血瘀,脑卒中后半身不遂等症。
决明子,是我国历史悠久的药用植物,最早《神农本草经》将决明子列为上品,称之“能治诸眼疾,久眼益精光,轻身。”决明子味甘、苦、咸,性微寒,善入肝、肾、大肠经,具有清肝明目、润肠通便的功效。决明子具有较好降血脂、降血压、抗氧化、抗衰老等疗效。现代药理学研究表明,决明子抑制血清胆固醇升高和动脉粥样硬化斑块的作用,降血脂效果显著,是国家卫生部公布的药食同源的物质之一。
菊花,性味甘苦,凉。具有疏风、清热、明目、解毒的功效 ,主治头痛、眩晕、目赤、心胸烦热、疔疮、肿毒。现代药理研究发现,菊花可以显著扩张心脏冠状动脉 ,增加冠脉血流量 ,并可提高心肌细胞对缺氧的耐受力。
菊苣,其性味微苦、咸、凉,具有清肝利胆、健胃消食、利尿消肿之功效,用于治疗湿热黄疸、胃痛食少、水肿尿少等病症。目前发现菊苣中主要含有多糖类、萜类、黄酮类和酚酸类等化学成分。其药理研究主要集中在保肝、抗菌、降血糖、调血脂和抗高尿酸血症等作用上。
槐米,味苦,微寒,具有凉血止血,清肝泻火等功效。近年来国内外医药工作者对其作用进行研究,发现其有效成分有抗癌防癌、抗血小板聚集、镇痛、抗菌、抗病毒、抗衰老、抗炎、抗过敏、抗自由基及抗氧化等多种活性,对改善心肌循环、清热解毒、降血脂、软化血管、消炎补肾等有良好的防治作用,对人体无毒、无害、无致死、致癌、致畸、致突变作用。
银杏叶,据《食疗本草》记载,银杏叶可用于心悸怔忡、肺虚咳喘等病症。经研究发现,银杏叶中以黄酮为主的有效成份,具有保护毛细血管通透性、扩张冠状动脉、恢复动脉血管弹性、营养脑细胞及其它器官的作用,而且还有使动脉、末梢血管、毛细血管中的血质与胆固醇维持正常水平的奇特功效。
余甘子,甘、微涩,凉。清热利咽,润肺止咳。用于感冒发热,咽喉痛,咳嗽,口千烦渴,耳痛,维生素丙缺乏症,余甘子是一种较好的天然降脂药物,用于治疗糖尿病脂代谢紊乱所引起的高血脂有良好的效果,其疗效高于维生素E,对微血管病变和神经系统并发症也有一定的疗效。
低聚木糖是聚合糖类中增殖双歧杆菌功能最强的品种之一,它的功效性是其他聚合糖类的近20倍,人体胃肠道内没有水解低聚木糖的酶,所以其可直接进入大肠内优先为双歧杆菌所利用,促进双歧杆菌增殖同时产生多种有机酸。降低肠道PH值,抑制有害菌生长,使益生菌在肠道大量增殖,达到保健功效。
绿饮品不仅具有提神清心、清热解暑、消食化痰、去腻减肥、清心除烦、解毒醒酒、生津止渴、降火明目、止痢除湿等药理作用,还有延缓衰老,抑制心血管疾病的功效。
与现有技术相比,本发明的有益效果是:
(1)本发明对中药材进行了合理的搭配,选用天然食用药为原料,各
组分符合药政规定,无毒副作用,对动脉硬化病人出现的常见症状如心悸、心慌、胸痛、胸闷、头痛、头晕、四肢凉麻、四肢酸懒、跛行、视力降低、记忆力下降、失眠、多梦等等都有良好的调理和治疗效果,对于城市居民、从事紧张脑力劳动者、肥胖、嗜烟、高血压、糖尿病、高脂血症患及易患此病的人群也有良好的预防效果,本药物的突出效果是无毒副作用,无不良反应,根治效率高。
(2)搭配合理,使每一味药材都能保留良好的药效,进而大大提高保健饮品中的中药利用率。
(3)口感良好,能够容易坚持服用,适合人们饮用。
(4)原材料成本低廉,制备工艺简单,降低生产成本。
具体实施方式
下面通过对实施例的描述,对本发明的具体实施方式作进一步详细的说明,以帮助本领域的技术人员对本发明的发明构思、技术方案有更完整、准确和深入的理解。
实施例1:
一种预防和治疗动脉硬化的保健饮品,由A组分和B组分组成, 所述A组分按重量份计,由以下重量份数的原料组成,山楂50份,葛根80份、绿饮品25份、苦荞麦50份、黄精100份 ;
所述B组分按重量份计,由以下原料组成,槐米60份、决明子10份、菊花10份、菊苣30份、桑叶25份。
制备方法如下:
(1)按照原料配比称重、去杂,清洗,然后微波烘干;
(2)将黄精按照古法三蒸三晒,苦荞麦在100℃的条件下进行60分钟烘培处理;
(3)将原料混合研磨成50目的粗粉;
(4)微波杀菌后饮品滤纸包装成8克/包,即为成品。
实施例2:
一种预防和治疗动脉硬化的保健饮品,由A组分和B组分组成,所述
A组分按重量份计,由以下重量份数的原料组成,山楂90份,葛根55份、绿饮品57.5份、苦荞麦105份、黄精70份;
所述B组分按重量份计,由以下原料组成,槐米40份、决明子20份、菊花15份。
制备方法与实施例1不同之处在于,步骤(2)将黄精按照古法三蒸三晒,苦荞麦在120℃的条件下进行50分钟烘培处理。
本实施例中,绿茶,选用的是鑫源饮品语的桑抹茶;
鑫源饮品语的桑抹茶具有降血糖、降血压、降血脂,具有类似人参的补益和抗衰老作用。并且含有粗蛋白质、碳水化合物、醚的浸出物、无机物及其他成分,仅粗蛋白质中就含有17 种氨基酸,其中15种为人体必需氨基酸。
实施例3:
一种预防和治疗动脉硬化的保健饮品,由A组分和B组分组成,所述A组分按重量份计,由以下重量份数的原料组成,山楂130份,
葛根30份、绿饮品90份、苦荞麦160份、黄精40份;
所述B组分按重量份计,由以下原料组成,槐米50份、低聚木糖5.5份。
绿茶,选用的是鑫源饮品语的桑抹茶;
制备方法与实施例1不同之处在于,步骤(2)将黄精按照古法三蒸三晒,苦荞麦在130℃的条件下进行55分钟烘培处理。
实施例4:
一种预防和治疗动脉硬化的保健饮品,由A组分和B组分组成, 所述A组分按重量份计,由以下重量份数的原料组成,山楂55份,葛根45份、绿茶50份、苦荞麦60份、黄精60份;
所述B组分按重量份计,由以下原料组成,槐米30份,低聚木糖10份。
制备方法与实施例1不同之处在于,步骤(2)将黄精按照古法三蒸三晒,苦荞麦在140℃的条件下进行40分钟烘培处理。
本次实施例1-4制备成保健茶成品,同样根据需要,也可以制备成固体饮料。
临床资料:
本发明以中医动脉硬化为例,经100例临床观察。选择中医诊断动脉硬化为标准:体质虚弱,肢软乏力,心慌、心悸、气紧,头晕眼花,睡眠欠佳或多睡,四肢发麻,心肌缺血,如上症状,即可确诊。在确诊观察的对象中,男性30例,女性70例,无其它严重疾病,年龄为30岁 -79 岁。
疗效判定:
(1)显效:体质增强,身上有劲,心慌、心悸、气紧,肢体麻木,心肌缺血,头昏眼花、睡眠欠佳等症状明显缓解。
(2)有效:体质增强,心慌、心悸、气紧,麻木等症状有所缓解。
(3)无效:病症无变化。
临床实验时,停服其它药物和保健营养品。服用本发明保健饮品, 观察3个月,为
一个疗程。服用方法:每日2包,每次1包,每包 含生药粉8克,沸水浸泡10-20分钟后频饮,服
用3个月后,疗效如 下表所示:
序号 | 病患(例) | 显效 | 有效 | 无效 | 总有效率 |
实施例1 | 25 | 18 | 7 | 0 | 100% |
实施例2 | 25 | 22 | 3 | 0 | 100% |
实施例3 | 25 | 21 | 4 | 0 | 100% |
实施例4 | 25 | 20 | 5 | 0 | 100% |
临床实验结果表明:实施例1-4对预防和治疗动脉硬化均有很好 的疗效,其中实施例2优于实施例3,实施例3优于实施例4,实施例4 优于实施例1。
典型病例:
例1、姚某、女62岁,德惠市大房身村人,2005年5月10日初诊。自述间断性头晕、头痛、耳鸣、手麻、下肢无力犹如踩棉花感三年余,头晕、耳鸣加重2个月。既往史:高血压、高血脂。测血压200/120mmhg;TCDTCD 示:左侧大脑前动脉和右椎动脉流速减慢,诊断:1. 脑动脉硬化,2. 颈椎病。3.高血脂。经服用本发明保健饮品两个疗程即6个月后症状体征消除,血压稳定,随访七年未复发。
例2、王某,男 62 岁,德惠市人,临床表现为,头晕,偶发心绞痛,周身不适已数年,舌红,苔少,脉弦细,经医院确诊为动脉硬化,肾动脉硬化,服用本发明保健饮品一日两次,两周后头晕,心绞痛的发生次数有所减少,周身不适感有所减轻,继续服用本发明的保健饮品三个月后,临床症状全无,病情痊愈。
例3、杨某,女54岁,德惠市人,2017年3月2日初诊,自述头晕,耳鸣,眼花,1年多,伴有乏力、气短、心慌、多梦。既往史:颞颌关节炎。血压:100/60mmhg,经医院诊断为脑动脉硬化。给予本发明的保健饮品1个月量。同年4月5日复诊:头已不昏,眼花乏力、气短、多梦等均有好转,嘱其继续服用1个疗程后,临床症状全无。
显然本发明具体实现并不受上述方式的限制,只要采用了本发明的方法构思和技术方案进行的各种非实质性的改进,或未经改进将本发明的构思和技术方案直接应用于其它场合的,均在本发明的保护范围之内。
Claims (5)
1.一种预防和治疗动脉硬化的保健饮品,其特征在于:由A组分和B组分组成,所述A组分,由以下原料组成,山楂,葛根、绿茶、苦荞麦、黄精 ;
所述B组分,由以下原料中的至少一种组成,黄芪、槐米、决明子、菊花、菊苣、银杏叶、桑叶、余甘子、低聚木糖,以上原料为干料。
2.根据权利要求1所述的预防和治疗动脉硬化的保健饮品,其特征在于:所述A组分按重量份计,由以下重量份数的原料组成,山楂50-130份,葛根30-80份、绿茶25-90份、苦荞麦50-160份、黄精40-100份 ;
所述B组分按重量份计,由以下重量份数的原料中的至少一种组成,黄芪30-80份、槐米20-60份、决明子10-30份、菊花10-20份、菊苣30-50份、银杏叶20-40份、桑叶25-45份、余甘子1-100份、低聚木糖1-10份。
3.根据权利要求2所述的预防和治疗动脉硬化的保健饮品,其特征在于:所述A组分按重量份计,由以下重量份数的原料组成,山楂90份,葛根55份、绿饮品57.5份、苦荞麦105份、黄精70份 ;
所述B组分按重量份计,由以下重量份数的原料中的至少一种组成,黄芪55份、槐米40份、决明子20份、菊花15份、菊苣40份、银杏叶30份、桑叶35份、余甘子50.5份、低聚木糖5.5份。
4.一种应用权利要求1-3任一项所述的预防和治疗动脉硬化的保健饮品的制备方法,其特征在于:包括以下工艺步骤:
(1)按照原料配比称重、去杂,清洗,然后微波烘干;
(2)将黄精按照古法三蒸三晒,苦荞麦在100-140℃的条件下进行40-60分钟烘培处理;
(3)将原料混合研磨成50目的粗粉;
(4)微波杀菌后茶滤纸包装成8克/包,即为保健茶成品。
5.一种应用权利要求1-3任一项所述的预防和治疗动脉硬化的保健饮品的制备方法,其特征在于:包括以下工艺步骤:
(1)按照原料配比称重、去杂,清洗,然后微波烘干;
(2)将黄精按照古法三蒸三晒,苦荞麦在100-140℃的条件下进行40-60分钟烘培处理;
(3)将烘培好的苦荞麦用超微粉碎机粉碎成超微粉,要求400目以上,再将其它原料混合,放入提取罐加水按照中药提取方法进行提取,将提取液浓缩至浸膏后同苦荞麦超微粉混合烘干打粉制成粉剂;
(4)将制成的粉剂用食品级包装袋包装成5克/包,即为固体饮料成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710733034.5A CN107519395A (zh) | 2017-08-24 | 2017-08-24 | 一种预防和治疗动脉硬化的保健饮品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710733034.5A CN107519395A (zh) | 2017-08-24 | 2017-08-24 | 一种预防和治疗动脉硬化的保健饮品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107519395A true CN107519395A (zh) | 2017-12-29 |
Family
ID=60682154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710733034.5A Pending CN107519395A (zh) | 2017-08-24 | 2017-08-24 | 一种预防和治疗动脉硬化的保健饮品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107519395A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011496A (zh) * | 2007-02-13 | 2007-08-08 | 崔萍 | 一种活血化瘀茶 |
CN101336965A (zh) * | 2008-08-07 | 2009-01-07 | 梁红梅 | 一种用于改善糖耐量、降低血糖的中成药及其制备方法 |
CN106889267A (zh) * | 2017-01-23 | 2017-06-27 | 邦盈生物医药科技股份有限公司 | 一种降血压血脂血糖养生茶及其制备方法 |
-
2017
- 2017-08-24 CN CN201710733034.5A patent/CN107519395A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011496A (zh) * | 2007-02-13 | 2007-08-08 | 崔萍 | 一种活血化瘀茶 |
CN101336965A (zh) * | 2008-08-07 | 2009-01-07 | 梁红梅 | 一种用于改善糖耐量、降低血糖的中成药及其制备方法 |
CN106889267A (zh) * | 2017-01-23 | 2017-06-27 | 邦盈生物医药科技股份有限公司 | 一种降血压血脂血糖养生茶及其制备方法 |
Non-Patent Citations (2)
Title |
---|
白鸿: "《保健食品功效成分检测方法》", 31 May 2011, 中国中医药出版社 * |
詹益兴: "《绿色精细化工 天然产品制造法 第1集》", 31 May 2005, 科学技术文献出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN102198262B (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
CN104642654A (zh) | 一种控制体重并降低尿酸降三高保健茶 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN105079465A (zh) | 一种降低血糖的组合物 | |
CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
CN110150415A (zh) | 一种安神通便预防三高的茶饮及其制备方法 | |
CN103740563B (zh) | 抗疲劳益肾养生酒及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN107034118A (zh) | 一种静心安神营养醋及其制作工艺 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN105079494A (zh) | 一种降血糖的铁皮石斛胶囊及其制备方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN105861252A (zh) | 一种灵芝保健米酒 | |
CN108310295B (zh) | 一种具有调理脾胃功能的中药组合物及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN107441404A (zh) | 一种用于气虚体质慢性疲劳综合征调理的中药方剂 | |
CN105311375A (zh) | 一种降低血脂的组合物 | |
CN107519395A (zh) | 一种预防和治疗动脉硬化的保健饮品及其制备方法 | |
CN109674014A (zh) | 用于花茶卤的组合物及制作方法 | |
CN103750425A (zh) | 一种高丽红参罗汉果汤的制备方法 | |
CN103830713B (zh) | 用于治疗鸡风寒型咳喘症的药物及其制备方法 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
CN107034094A (zh) | 一种舒筋通络蜂蜜保健酒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171229 |